Patent · US Expired

Procedure for immunologic determination of procollagen peptide (type III) and procollagen peptide col 1 (type III) together and a process for preparing anti-procollagen peptide col 1 (type III) serum

US4504587A · kind A · utility

48Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 11, 1983
Grant dateMar 12, 1985
Priority date
Expiry dateMar 11, 2003

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S436/824
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The antigens procollagen peptide (type (III) and procollagen peptide col 1 (type III) can be determined together immunologically by either PA0 (a) reacting a specified amount in each case of labeled procollagen peptide (type III) or procollagen peptide col 1 (type III) and a highly specific antiserum containing antibodies having affinity for both the antigens mentioned together with a sample having an unknown content of procollagen peptide (type III) and/or procollagen peptide col 1 (type III), separating off the antigen-antibody complex formed and measuring the amount of labeling in the complex and/or in the supernatant, or PA0 (b) bringing a specified amount of the highly specific antiserum to reaction with a sample having an unknown content of procollagen peptide (type III) and/or procollagen peptide col 1 (type III), fixing the unreacted amount of the antibody to procollagen peptide (type III) or procollagen peptide col 1 (type III) bound to a support, and bringing to reaction with a labeled second antibody, and then determining the amount of bound or excess second antibody by measuring the labeling. An anti-procollagen peptide col 1 (type III) serum is preferred as the highly …

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.